Recombinant Human S100A7A Protein，His

S100A7A, a member of the S100 protein family, is a calcium-binding protein primarily expressed in epithelial cells and has been implicated in various biological processes. Its dysregulation has been observed in several pathological conditions, including inflammatory diseases and certain types of cancer, making it of significant interest in biomedical research. Recent studies have highlighted its role as a potential biomarker and therapeutic target due to its involvement in modulating inflammation, cell proliferation, and apoptosis. The recombination and characterization of S100A7A protein allow researchers to elucidate its functional mechanisms in cellular signaling pathways and immune responses. By producing recombinant S100A7A, scientists can study its structure-function relationship, interactions with other proteins, and effects on cellular behavior. This research not only enhances our understanding of S100A7A's biological roles but also paves the way for developing novel diagnostic and therapeutic strategies targeting diseases associated with S100A7A dysregulation. As the advances in recombinant protein techniques continue to evolve, S100A7A stands out as a promising candidate for further exploration in the context of both basic and applied biomedical sciences.